
Topic
Chemotherapy
38 Podcasts • 21 Cases • 3 Courses on BackTable
Hear how experienced physicians approach Chemotherapy on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering patient selection, workup, and procedure technique. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.
Episode # 85 • 13 Oct 2026
Perioperative Management in Upper GI Cancers
How do you choose between perioperative chemotherapy and trimodality therapy for a patient with localized upper GI cancer, and what has the newest data actually settled? On this episode of BackTable Tumor Board, host Dr. Kate Baker interviews Dr. Dani Castillo, a medical oncologist at City of Hope in Duarte, California, and Dr. Alexandra Gangi, a gastrointestinal surgical oncologist at Cedars-Sinai in Los Angeles, about everything that happens between a new diagnosis and a resection in localized esophageal, gastroesophageal junction and gastric cancer. They cover diagnostic workup, Siewert classification, staging laparoscopy, histology, biomarker testing, surgical candidacy, and the challenges of nutrition and prehabilitation.
More on Chemotherapy
Loading recent podcasts…
Tumor Board # 85
Oct 12, 2026
with Dr. Dani Castillo, Dr. Alexandra Gangi, Dr. Kate Baker
How do you choose between perioperative chemotherapy and trimodality therapy for a patient with localized upper GI...
Tumor Board # 68
Jun 22, 2026
with Dr. Dawood Findakly, Dr. Gregory Botta
Can the latest therapies, lessons from clinical trials, and a focus on emotional support improve outcomes for patients...
Tumor Board # 56
Apr 20, 2026
with Dr. Jessica Jones, Dr. Lindsay Peterson
Here’s a practical guide on how biomarkers can guide treatment and cut costs for your breast cancer patients. In this...
Tumor Board # 55
Apr 13, 2026
with Dr. Shruti Patel, Dr. Jun Gong
How will the newest colorectal cancer trial results discussed at the 2026 ASCO GI Cancers Symposium in San Francisco...
Tumor Board # 70
Jun 29, 2026
with Dr. Chih-Yi Liao, Dr. Xavier Keutgen, Dr. Lingling Du
How do you unravel the complexity of diagnosing and managing neuroendocrine tumors, where every case demands a tailored...
Tumor Board # 62
Jun 1, 2026
with Dr. Rebekah White, Dr. Michael Sherer, Dr. Zach Berman
Can a tumor deemed permanently unresectable actually be downstaged to surgery? In this episode of BackTable Tumor...
CardioNerds # 446
Apr 15, 2026
with Dr. Manu Murali Mysore, Dr. Natalie Marrero, Dr. Shivani Reddy, Dr. Rebecca S. Steinberg
CardioNerds (Drs. Natalie Marrero, Shivani Reddy, and Rebecca S. Steinberg), discuss the role of SGLT2i in cancer...
Urology # 287
Jan 29, 2026
with Dr. Amanda Nizam, Dr. Brad McGregor, Dr. Alan Tan
Is the era of cisplatin over, or are we simply becoming more precise about who benefits from it? As perioperative...
1,500+ listens
Urology Case
Oct 11, 2026
with Dr. Kristen Scarpato, Dr. Jason Hafron and Dr. Ruchika Talwar
Urology Case
Sep 25, 2026
with Dr. Kristen Scarpato, Dr. Jason Hafron and Dr. Ruchika Talwar
Tumor Board Case
Sep 15, 2026
with Dr. Arsen Osipov, Dr. Daniel Ahn and Dr. Andrew Hendifar
Tumor Board Case
Jun 23, 2025
with Dr. Nirmish Singla, Dr. Jeannie Hoffman-Censits and Dr. Bogdana Schmidt
Urology Case
Sep 25, 2026
with Dr. Kristen Scarpato, Dr. Jason Hafron and Dr. Ruchika Talwar
Tumor Board Case
Oct 11, 2026
with Dr. Arsen Osipov, Dr. Daniel Ahn and Dr. Andrew Hendifar
Tumor Board Case
Jun 29, 2026
with Dr. Chih-Yi Liao, Dr. Xavier Keutgen and Dr. Lingling Du
Tumor Board Case
Jun 23, 2025
with Dr. Nirmish Singla, Dr. Jeannie Hoffman-Censits and Dr. Bogdana Schmidt
Tumor Board Course
2 CME/CE credits, 2.5 hours, 19 lessons
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.








